Cargando…

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer

Detalles Bibliográficos
Autor principal: Ruan, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522595/
https://www.ncbi.nlm.nih.gov/pubmed/34790842
http://dx.doi.org/10.4103/apjon.apjon-2164
_version_ 1784585114971275264
author Ruan, Ji
author_facet Ruan, Ji
author_sort Ruan, Ji
collection PubMed
description
format Online
Article
Text
id pubmed-8522595
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-85225952021-11-16 MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer Ruan, Ji Asia Pac J Oncol Nurs Editorial Wolters Kluwer - Medknow 2021-10-04 /pmc/articles/PMC8522595/ /pubmed/34790842 http://dx.doi.org/10.4103/apjon.apjon-2164 Text en Copyright: © 2021 Ann & Joshua Medical Publishing Co. Ltd https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Editorial
Ruan, Ji
MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
title MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
title_full MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
title_fullStr MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
title_full_unstemmed MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
title_short MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
title_sort met inhibitor is expected to overcome met amplification-induced immunotherapy resistance in non-small cell lung cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522595/
https://www.ncbi.nlm.nih.gov/pubmed/34790842
http://dx.doi.org/10.4103/apjon.apjon-2164
work_keys_str_mv AT ruanji metinhibitorisexpectedtoovercomemetamplificationinducedimmunotherapyresistanceinnonsmallcelllungcancer